HMGCR and Insulin resistance: HMGCR is the key enzyme in cholesterol synthesis and a primary target for statins,541 which reduce cholesterol by binding to the active site of HMGCR.542,543 Despite their effectiveness, statins sometimes cause side effects such as muscle damage and insulin resistance.544–548 To address these challenges, new PROTAC molecules have been developed targeting HMGCR.